阿司匹林與氯吡格雷預防或治療缺血性腦卒中致出血并發(fā)癥的系統(tǒng)評價
發(fā)布時間：2019-03-26 09:30
【摘要】：目的對阿司匹林與氯吡格雷預防或治療缺血性腦卒中(IS)導致出血并發(fā)癥風險進行評價。方法計算機檢索Pub Med、EMBase、The Cochrane Library、CBM、CNKI、VIP和Wang Fang Data等數(shù)據(jù)庫。檢索自建庫截止至2016年9月。搜集阿司匹林與氯吡格雷預防或治療IS且產(chǎn)生出血并發(fā)癥的隨機對照試驗(RCT)。由2位研究人員獨立進行文獻篩選、數(shù)據(jù)提取和質量評價后,采用Rev Man 5.2軟件進行Meta分析。結果共納入13個RCT,包括5204例患者。Meta分析結果顯示:(1)預防IS時,阿司匹林相比氯吡格雷不增加皮膚黏膜、牙齦出血風險,但增加消化道出血風險;阿司匹林和氯吡格雷聯(lián)用相比阿司匹林單用增加胃腸道反應。(2)治療IS時,阿司匹林相比氯吡格雷不增加皮膚黏膜、牙齦、消化道出血風險,不增加胃腸道反應;阿司匹林和氯吡格雷聯(lián)用相比阿司匹林單用亦不增加皮膚黏膜、牙齦、消化道、顱腦出血風險,不增加胃腸道反應。結論預防IS時,阿司匹林相比氯吡格雷會增加消化道出血風險,阿司匹林和氯吡格雷聯(lián)用相比阿司匹林單用會增加胃腸道反應。
[Abstract]:Objective To evaluate the risk of hemorrhagic complications caused by the prevention or treatment of ischemic stroke (IS) by aspirin and chlordecay. Methods The databases of Pub Med, EMBase, The Cochrane Library, CBM, CNKI, VIP and Wang Fang Data were retrieved from the computer. The self-built library was retrieved until September 2016. A randomized controlled trial (RCT) for the prevention or treatment of IS and the occurrence of bleeding complications with aspirin and chloringray. Literature screening, data extraction and quality evaluation were carried out independently by two researchers, and Meta-analysis was carried out by using the Rev Man 5.2 software. Results A total of 13 RCTs were included, including 5204 patients. The results of the meta-analysis showed that: (1) In the prevention of IS, the risk of bleeding of the gingival bleeding was not increased compared with that of the chloringray, but the risk of the bleeding of the digestive tract was increased; and the combination of the aspirin and the chloroforgrel alone increased the gastrointestinal reaction. (2) In the treatment of IS, the risk of the skin mucosa, the gum, the digestive tract and the bleeding of the digestive tract is not increased as compared with the aspirin, and the gastrointestinal reaction is not increased; and the combination of the aspirin and the chlorhexidine gluconate does not increase the risk of the skin mucous membrane, the gum, the digestive tract and the head bleeding, The gastrointestinal reaction is not increased. Conclusion In the prevention of IS, aspirin may increase the risk of bleeding in the digestive tract, compared with the use of aspirin alone, and the use of aspirin alone will increase the gastrointestinal reaction.
【作者單位】： 克拉瑪依市中心醫(yī)院神經(jīng)內(nèi)科;克拉瑪依市中心醫(yī)院藥劑科;四川大學華西醫(yī)院循證醫(yī)學中心;
【基金】：克拉瑪依市科委立項項目(JK2014-18)
【分類號】：R743.3
本文編號：2447415
[Abstract]:Objective To evaluate the risk of hemorrhagic complications caused by the prevention or treatment of ischemic stroke (IS) by aspirin and chlordecay. Methods The databases of Pub Med, EMBase, The Cochrane Library, CBM, CNKI, VIP and Wang Fang Data were retrieved from the computer. The self-built library was retrieved until September 2016. A randomized controlled trial (RCT) for the prevention or treatment of IS and the occurrence of bleeding complications with aspirin and chloringray. Literature screening, data extraction and quality evaluation were carried out independently by two researchers, and Meta-analysis was carried out by using the Rev Man 5.2 software. Results A total of 13 RCTs were included, including 5204 patients. The results of the meta-analysis showed that: (1) In the prevention of IS, the risk of bleeding of the gingival bleeding was not increased compared with that of the chloringray, but the risk of the bleeding of the digestive tract was increased; and the combination of the aspirin and the chloroforgrel alone increased the gastrointestinal reaction. (2) In the treatment of IS, the risk of the skin mucosa, the gum, the digestive tract and the bleeding of the digestive tract is not increased as compared with the aspirin, and the gastrointestinal reaction is not increased; and the combination of the aspirin and the chlorhexidine gluconate does not increase the risk of the skin mucous membrane, the gum, the digestive tract and the head bleeding, The gastrointestinal reaction is not increased. Conclusion In the prevention of IS, aspirin may increase the risk of bleeding in the digestive tract, compared with the use of aspirin alone, and the use of aspirin alone will increase the gastrointestinal reaction.
【作者單位】： 克拉瑪依市中心醫(yī)院神經(jīng)內(nèi)科;克拉瑪依市中心醫(yī)院藥劑科;四川大學華西醫(yī)院循證醫(yī)學中心;
【基金】：克拉瑪依市科委立項項目(JK2014-18)
【分類號】：R743.3
【相似文獻】
相關期刊論文 前10條
1 張秋華,鄧雪珍;30例重型腦出血并發(fā)癥的相關因素與預防對策[J];心血管康復醫(yī)學雜志;2001年02期
2 宋善俊;;抗凝治療的出血并發(fā)癥[J];國外醫(yī)學參考資料(內(nèi)科學分冊);1975年12期
3 李景慧,孫軍,董洪珍,李德清,李敏,孫秀清,白浩瑞,許鳳華,張敏;腦出血并發(fā)癥100例臨床治療體會[J];黑龍江醫(yī)學;1995年02期
4 郁剛;;腦出血并發(fā)癥的防治[J];中國實用醫(yī)藥;2009年17期
5 李梅云;腦出血并發(fā)癥的發(fā)生機制與處置[J];臨床薈萃;2001年02期
6 王相亭;腦出血并發(fā)癥257例分析[J];江蘇臨床醫(yī)學雜志;1999年04期
7 秦桂云;梅巖;李春玉;謝今宜;李彤;;腦出血并發(fā)癥的預防及護理[J];中國中醫(yī)藥現(xiàn)代遠程教育;2010年03期
8 呂金新;;腦出血并發(fā)癥的治療[J];中國醫(yī)藥指南;2010年36期
9 賀道華;t-PA溶栓引起的腦出血并發(fā)癥[J];中國微侵襲神經(jīng)外科雜志;2001年03期
10 鄭傼萱;;腦出血并發(fā)癥的處理[J];中國社區(qū)醫(yī)師;1993年12期
，本文編號：2447415
本文鏈接：http://sikaile.net/yixuelunwen/shenjingyixue/2447415.html
最近更新
教材專著
